Skip to main content

Advertisement

SpringerLink
Log in

Scalp psoriasis in a haemodialysis patient successfully treated with a half-dose of apremilast

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kishimoto K, Komine M, Hioki T, Kamiya K, Sugai J, Ohtsuki M. Real-world use of apremilast for patients with psoriasis in Japan. J Dermatol 2018; 45: 1345–8.

    Article  CAS  Google Scholar 

  2. Ohata C, Ohyama B, Kuwahara F, Katayama E, Nakama T. Realworld data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis. J Dermatolog Treat 2018: 1–4.

    Google Scholar 

  3. Schafer P, Parton A, Capone L, et al. Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cell Signal 2014; 26: 2016–29.

    Article  CAS  Google Scholar 

  4. Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol 2012; 83: 1583–90.

    Article  CAS  Google Scholar 

  5. Ohtsuki M. Oral apremilast for psoriasis. Rinsho Hifuka (Japanese) 2017; 71: 114–9.

    Google Scholar 

  6. Rich P, Gooderham M, Bachelez H, et al. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). J Am Acad Dermatol 2016; 74: 134–42.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan

    Mayumi Nagata, Masahiro Kamata & Yayoi Tada

  2. Department of Dermatology, Sanno Hospital, Tokyo, Japan

    Mayumi Nagata, Mamitaro Ohtsuki & Sayuri Sato

  3. Department of Dermatology, Jichi Medical University, Shimotsuke, Japan

    Mamitaro Ohtsuki

Authors
  1. Mayumi Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masahiro Kamata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mamitaro Ohtsuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sayuri Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yayoi Tada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masahiro Kamata.

Ethics declarations

Disclosure. Conflicts of interest: M.K. received grants for research from Torii Pharmaceutical, Eisai, Maruho, Novartis Pharma, and honoraria for lectures from Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceutical. M.O. received grants for research and/or honoraria for lectures and/or advisory board from Abbvie, Boehringer-Ingelheim, Celgene, Eisai, Eli Lilly, Janssen, Kyowa Hakko Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe Pharma,Novartis, Pfizer, Taiho Pharmaceutical, and Torii Pharmaceutical. Y.T. received a grant for research from Maruho, LEO Pharma, Eisai, Abb-Vie, Kyowa Hakko Kirin, Taiho Pharmaceutical, Celgene, and Eli Lilly, and honoraria for lectures from Maruho, LEO Pharma, Eisai, AbbVie,Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceutical. Funding source: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagata, M., Kamata, M., Ohtsuki, M. et al. Scalp psoriasis in a haemodialysis patient successfully treated with a half-dose of apremilast. Eur J Dermatol 29, 341–342 (2019). https://doi.org/10.1684/ejd.2019.3588

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2019.3588

Search

Navigation